VECTOR SCIENCE AND THERAPEUTICS CORP.

Valuation Vector Science and Therapeutics Corp.

Stocks

PAIN

CA92244M1041

Investment Holding Companies

Market Closed - Toronto S.E. Other stock markets 22:59:59 23/06/2026 +03			5-day change	1st Jan Change
2.430 ^CAD	-2.02%		+11.47%	+4,760.00%

06-12	Vector Science & Therapeutics Corp. Announces Appointment of Dexter Fowler as Chief Athletic Officer for Its Valor Platform	CI
06-08	Vector Science & Therapeutics Corp. Announces Appointment of Darryl Drake Jr. as President of Valor and Chairman of the Athletic Board of Directors	CI

Company Valuation: Vector Science and Therapeutics Corp.

Data adjusted to current consolidation scope

Fiscal Period: August	2025
Market Cap ¹	0.1109
Change	-
Enterprise Value (EV) ¹	-2.771
Change	-
P/E	-0.29x
PBR	0.15x
PEG	-
Capitalization / Revenue	-
EV / Revenue	-
EV / EBITDA	-
EV / EBIT	6.06x
EV / FCF	-
FCF Yield	-
Dividend per Share ²	-
Rate of return	-
EPS ²	-0.1292
Distribution rate	-
Net sales	-
EBITDA	-
EBIT ¹	-0.4571
Net income ¹	-0.898
Net Debt ¹	-2.882
Reference price ²	0.037
Nbr of stocks (in thousands)	3,000
Announcement Date	4/14/26 A

¹USD in Million²USD

Estimates

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
	VECTOR SCIENCE AND THERAPEUTICS CORP.	-	-	-	-	262M
	CENTIEL AG	59.52x	10.19x	49.2x	-	859M
	Average	59.52x	10.19x	49.20x		560.59M
	Weighted average by Cap.	59.52x	10.19x	49.20x

See all sector valuations

Income Statement and Estimates

More financial data

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Stock Market
Stocks
PAIN Stock
Valuation Vector Science and Therapeutics Corp.

-40%: Exceptional extension

SEIZE THE OFFER!